Episode 273: ESMO 2023: Toripalimab and Axitinib in Clear Cell RCC

Xinan Sheng, MD, joins the podcast to discuss the RENOTORCH trial on toripalimab plus axitinib for advanced RCC in intermediate- and poor-risk patients that was presented at ESMO 2023.
Dr. Sheng is from the Department of Genitourinary Oncology at Peking University Cancer Hospital & Institute in Beijing, China.